Tempus AI Share Holder Equity 2023-2025 | TEM

Tempus AI share holder equity from 2023 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Tempus AI share holder equity for the quarter ending September 30, 2025 was $0.508B, a 845.18% increase year-over-year.
  • Tempus AI share holder equity for 2024 was $0.056B, a 104.08% decline from 2023.
  • Tempus AI share holder equity for 2023 was $-1.382B, a 22.42% increase from 2022.
  • Tempus AI share holder equity for 2022 was $-1.129B, a 0% decline from .
Tempus AI Annual Share Holder Equity
(Millions of US $)
2024 $56
2023 $-1,382
2022 $-1,129
Tempus AI Quarterly Share Holder Equity
(Millions of US $)
2025-09-30 $508
2025-06-30 $310
2025-03-31 $326
2024-12-31 $56
2024-09-30 $54
2024-06-30 $98
2024-03-31 $-1,474
2023-12-31 $-1,382
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $-1,129
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.183B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.084B 58.67
Doximity (DOCS) United States $9.342B 38.47
Hims & Hers Health (HIMS) United States $8.418B 68.48
IRhythm Technologies (IRTC) United States $5.504B 0.00
Hinge Health (HNGE) United States $3.224B 0.00
Privia Health (PRVA) United States $2.884B 180.38
Inspire Medical Systems (INSP) United States $2.509B 41.51
Heartflow (HTFL) United States $2.383B 0.00
10x Genomics (TXG) United States $2.011B 0.00
Enovis (ENOV) United States $1.715B 9.01
Omnicell (OMCL) United States $1.576B 32.22
Azenta (AZTA) United States $1.364B 59.50
Phreesia (PHR) United States $1.304B 0.00
Schrodinger (SDGR) United States $1.299B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Fulgent Genetics (FLGT) United States $0.900B 0.00
Claritev (CTEV) United States $0.715B 0.00
Talkspace (TALK) United States $0.538B 108.33
Butterfly Network (BFLY) United States $0.536B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.477B 0.00
Evolent Health (EVH) United States $0.466B 0.00
Carlsmed (CARL) United States $0.349B 0.00
Zepp Health (ZEPP) Netherlands $0.348B 0.00
TruBridge (TBRG) United States $0.306B 14.05
SOPHiA GENETICS SA (SOPH) Switzerland $0.291B 0.00
CapsoVision (CV) United States $0.239B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.200B 0.00
MDxHealth SA (MDXH) Belgium $0.172B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
Health Catalyst (HCAT) United States $0.160B 0.00
CareCloud (CCLD) United States $0.133B 7.28
EUDA Health Holdings (EUDA) Singapore $0.110B 0.00
Outset Medical (OM) United States $0.085B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
American Well (AMWL) United States $0.066B 0.00
Pulmonx (LUNG) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
Evaxion - (EVAX) Denmark $0.045B 0.00
111 (YI) China $0.035B 0.00
Precipio (PRPO) United States $0.031B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.025B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.015B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00